Copyright © 2021 Aavalium, Inc.   All rights reserved.

Aavalium targets niche, difficult-to-source, and/or difficult-to-manufacture pharmaceutical products for the US market.  Our product pipeline consists of products ranging from generic and 505(b)(2) to NCEs, covering a wide range of therapeutic areas and dosage forms. We aim to out-license our products to business partners for further development and/or commercialization. We also look for partnership opportunities to co-develop new products.